IIMA Ventures, formerly known as CIIE, has announced a significant funding initiative aimed at bolstering India’s dynamic entrepreneurial landscape. The esteemed organization, recognized as a Centre of Excellence by the Department of Science and Technology and rooted in the prestigious IIM Ahmedabad since 2002, has raised a commendable amount in its latest round of financing. This funding will empower IIMA Ventures to expand its comprehensive innovation continuum, which encompasses incubation, acceleration, seed and growth funding, and vital research. Over the years, IIMA Ventures has proven to be a game-changer in addressing the multifaceted challenges of India’s innovation ecosystem, having successfully accelerated more than 1,000 startups, funded over 300 ventures, and mentored over 5,000 entrepreneurs. This new capital will enable IIMA Ventures to further innovate and implement programs that strengthen its commitment to fostering entrepreneurial excellence. Notable programs include India's first accelerator, iAccelerator, and INFUSE Ventures, the nation’s only cleantech-focused fund. By collaborating with corporates, government bodies, and academic institutions, IIMA Ventures has continually adapted its offerings to meet the needs of aspiring entrepreneurs. This funding round is not just a financial boost; it represents a renewed commitment to inspire India’s next wave of innovators and leaders. For anyone interested in joining this transformative journey, IIMA Ventures invites inquiries and collaborations at info@ciie.co. Together, we can continue to fuel the entrepreneurial spirit that drives India toward a prosperous and innovative future.
IIMA Ventures Secures Pre-Seed Funding to Fuel Innovation: A Major Milestone in India's Entrepreneurship Ecosystem
Get the full IIMA Ventures company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Caseway Canada | Pre-seed | $1.5M | today |
| 2 |  Orakle Weather France | Pre-seed | $550.0K | today |
| 3 |  hi finance Canada | Pre-seed | $500.0K | 1d ago |
| 4 |  Publicit Spain | Pre-seed | $813.4K | 1d ago |
| 5 |  Autentica CarParts - UK United Kingdom | Pre-seed | $1.2M | 1d ago |